<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 23 Jun 2026 07:42:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  424B3      TRINITY BIOTECH PLC                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26675913.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675913.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26675913.html</guid>
   <pubDate>Tue, 23 Jun 2026 07:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  424B3      TRINITY BIOTECH PLC                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26675913.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675913.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26675913.html</guid>
   <pubDate>Tue, 23 Jun 2026 07:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  6-K        TRINITY BIOTECH PLC       For: Jun 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+23/26675903.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675903.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+23/26675903.html</guid>
   <pubDate>Tue, 23 Jun 2026 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  6-K        TRINITY BIOTECH PLC       For: Jun 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+23/26675903.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675903.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+23/26675903.html</guid>
   <pubDate>Tue, 23 Jun 2026 07:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech launches Trinovium subsidiary for AI data center cooling</title>
   <link>http://www.streetinsider.com/Corporate+News/Trinity+Biotech+launches+Trinovium+subsidiary+for+AI+data+center+cooling/26675856.html</link>
   <description>&lt;p&gt;Trinity Biotech plc (NASDAQ: TRIB) announced the launch of Trinovium, a new subsidiary focused on liquid cooling solutions for AI data centers, according to a company press release dated June 23, 2026.&lt;/p&gt;&lt;p&gt;The Dublin-based biotechnology company said Trinovium will apply its existing high-purity fluid manufacturing capabilities, developed for healthcare applications, to the data center liquid cooling market. Trinity Biotech said it will redirect a portion of its existing U.S. and European Union manufacturing capacity — capable of producing millions of liters of high-precision fluids annually — to support the new subsidiary.&lt;/p&gt;&lt;p&gt;The data center liquid cooling market is projected to grow from</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Trinity+Biotech+launches+Trinovium+subsidiary+for+AI+data+center+cooling/26675856.html</guid>
   <pubDate>Tue, 23 Jun 2026 07:30:55 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market</title>
   <link>http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Launches+Trinovium+to+Bring+Healthcare-Grade+Fluid+Technology+to+the+Rapidly+Growing+Multi-Billion+Dollar+AI+Data+Center+Liquid+Cooling+Market/26675825.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;em&gt;- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-performance computing environments&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033&lt;sup&gt;1&lt;/sup&gt;&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, Ireland and WILSONVILLE, Ore., June  23, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today announced the launch of Trinovium, a dedicated subsidiary focused on advanced liquid cooling solutions and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Launches+Trinovium+to+Bring+Healthcare-Grade+Fluid+Technology+to+the+Rapidly+Growing+Multi-Billion+Dollar+AI+Data+Center+Liquid+Cooling+Market/26675825.html</guid>
   <pubDate>Tue, 23 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market</title>
   <link>http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Launches+Trinovium+to+Bring+Healthcare-Grade+Fluid+Technology+to+the+Rapidly+Growing+Multi-Billion+Dollar+AI+Data+Center+Liquid+Cooling+Market/26675825.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;em&gt;- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-performance computing environments&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033&lt;sup&gt;1&lt;/sup&gt;&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, Ireland and WILSONVILLE, Ore., June  23, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today announced the launch of Trinovium, a dedicated subsidiary focused on advanced liquid cooling solutions and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Launches+Trinovium+to+Bring+Healthcare-Grade+Fluid+Technology+to+the+Rapidly+Growing+Multi-Billion+Dollar+AI+Data+Center+Liquid+Cooling+Market/26675825.html</guid>
   <pubDate>Tue, 23 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Launches+Trinovium+to+Bring+Healthcare-Grade+Fluid+Technology+to+the+Rapidly+Growing+Multi-Billion+Dollar+AI+Data+Center+Liquid+Cooling+Market/26675825.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;em&gt;- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-performance computing environments&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033&lt;sup&gt;1&lt;/sup&gt;&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, Ireland and WILSONVILLE, Ore., June  23, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today announced the launch of Trinovium, a dedicated subsidiary focused on advanced liquid cooling solutions and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Launches+Trinovium+to+Bring+Healthcare-Grade+Fluid+Technology+to+the+Rapidly+Growing+Multi-Billion+Dollar+AI+Data+Center+Liquid+Cooling+Market/26675825.html</guid>
   <pubDate>Tue, 23 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Launches+Trinovium+to+Bring+Healthcare-Grade+Fluid+Technology+to+the+Rapidly+Growing+Multi-Billion+Dollar+AI+Data+Center+Liquid+Cooling+Market/26675825.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;em&gt;- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-performance computing environments&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033&lt;sup&gt;1&lt;/sup&gt;&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, Ireland and WILSONVILLE, Ore., June  23, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today announced the launch of Trinovium, a dedicated subsidiary focused on advanced liquid cooling solutions and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Launches+Trinovium+to+Bring+Healthcare-Grade+Fluid+Technology+to+the+Rapidly+Growing+Multi-Billion+Dollar+AI+Data+Center+Liquid+Cooling+Market/26675825.html</guid>
   <pubDate>Tue, 23 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  424B3      TRINITY BIOTECH PLC                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26666861.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666861.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26666861.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  424B3      TRINITY BIOTECH PLC                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26666861.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26666861.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26666861.html</guid>
   <pubDate>Thu, 18 Jun 2026 16:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  6-K        TRINITY BIOTECH PLC       For: Jun 18</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+18/26665345.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26665345.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+18/26665345.html</guid>
   <pubDate>Thu, 18 Jun 2026 14:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  6-K        TRINITY BIOTECH PLC       For: Jun 18</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+18/26665345.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26665345.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+18/26665345.html</guid>
   <pubDate>Thu, 18 Jun 2026 14:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets&lt;/em&gt; &lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Company publishes Q1 2026 financial results with revenue in line with prior guidance &amp;amp; substantial year-on-year gross margin percentage improvements&lt;/em&gt;            &lt;em&gt; &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, June  16, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received additional purchase orders for over 2 million units of its flagship rapid HIV test, TrinScreen™ HIV. These orders are scheduled for fulfillment in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.13092795</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03297629</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets&lt;/em&gt; &lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Company publishes Q1 2026 financial results with revenue in line with prior guidance &amp;amp; substantial year-on-year gross margin percentage improvements&lt;/em&gt;            &lt;em&gt; &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, June  16, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received additional purchase orders for over 2 million units of its flagship rapid HIV test, TrinScreen™ HIV. These orders are scheduled for fulfillment in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.13092795</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03297629</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets&lt;/em&gt; &lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Company publishes Q1 2026 financial results with revenue in line with prior guidance &amp;amp; substantial year-on-year gross margin percentage improvements&lt;/em&gt;            &lt;em&gt; &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, June  16, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received additional purchase orders for over 2 million units of its flagship rapid HIV test, TrinScreen™ HIV. These orders are scheduled for fulfillment in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.13092795</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03297629</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets&lt;/em&gt; &lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Company publishes Q1 2026 financial results with revenue in line with prior guidance &amp;amp; substantial year-on-year gross margin percentage improvements&lt;/em&gt;            &lt;em&gt; &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, June  16, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received additional purchase orders for over 2 million units of its flagship rapid HIV test, TrinScreen™ HIV. These orders are scheduled for fulfillment in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.13092795</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03297629</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets&lt;/em&gt; &lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Company publishes Q1 2026 financial results with revenue in line with prior guidance &amp;amp; substantial year-on-year gross margin percentage improvements&lt;/em&gt;            &lt;em&gt; &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, June  16, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received additional purchase orders for over 2 million units of its flagship rapid HIV test, TrinScreen™ HIV. These orders are scheduled for fulfillment in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.13092795</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03297629</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets&lt;/em&gt; &lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Company publishes Q1 2026 financial results with revenue in line with prior guidance &amp;amp; substantial year-on-year gross margin percentage improvements&lt;/em&gt;            &lt;em&gt; &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, June  16, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received additional purchase orders for over 2 million units of its flagship rapid HIV test, TrinScreen™ HIV. These orders are scheduled for fulfillment in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.13092795</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03297629</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets&lt;/em&gt; &lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Company publishes Q1 2026 financial results with revenue in line with prior guidance &amp;amp; substantial year-on-year gross margin percentage improvements&lt;/em&gt;            &lt;em&gt; &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, June  16, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received additional purchase orders for over 2 million units of its flagship rapid HIV test, TrinScreen™ HIV. These orders are scheduled for fulfillment in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.13092795</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03297629</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets&lt;/em&gt; &lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;– Company publishes Q1 2026 financial results with revenue in line with prior guidance &amp;amp; substantial year-on-year gross margin percentage improvements&lt;/em&gt;            &lt;em&gt; &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;DUBLIN, June  16, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received additional purchase orders for over 2 million units of its flagship rapid HIV test, TrinScreen™ HIV. These orders are scheduled for fulfillment in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Trinity+Biotech+Awarded+Significant+Orders+for+Over+2+Million+TrinScreen+HIV+Tests+And+Reports+Q1+2026+Financial+Results/26651700.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.13092795</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03297629</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  424B3      TRINITY BIOTECH PLC                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26646264.html</link>
   <description>si-local-file:///var/storage/secattach/20260615/26646264.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26646264.html</guid>
   <pubDate>Mon, 15 Jun 2026 12:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  424B3      TRINITY BIOTECH PLC                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26646264.html</link>
   <description>si-local-file:///var/storage/secattach/20260615/26646264.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B3++++++TRINITY+BIOTECH+PLC++++++++++++++++++/26646264.html</guid>
   <pubDate>Mon, 15 Jun 2026 12:36:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  6-K        TRINITY BIOTECH PLC       For: Jun 12</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+12/26641405.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641405.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+12/26641405.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
  <item>
   <title>Form  6-K        TRINITY BIOTECH PLC       For: Jun 12</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+12/26641405.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641405.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TRINITY+BIOTECH+PLC+++++++For%3A+Jun+12/26641405.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.05996367</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
   	  </item>
 </channel>
</rss>
